Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum

Hiroyuki Ikari, Zhang Liang, Jeffrey M. Chernak, Andrea Mastrangeli, Shuichi Kato, Hui Kuo, Ronald Crystal, Donald K. Ingram, George S. Roth

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A robust feature of mammalian aging associated with diminished motor control is the loss of dopamine D2 receptors from the neostriatum. Decline in this neurotransmitter receptor is also observed in neurodegenerative disorders, such as Huntington's disease and late-stage Parkinson's disease. We have constructed a replication-deficient adenoviral vector to transfer rat dopamine D2 receptor cDNA to brain as a possible therapeutic strategy. Using tissue culture cells infected with this vector, we detected dopamine D2 receptor mRNA by Northern analysis and functional receptor protein in membrane preparations as specific binding of the dopamine D2 receptor ligand, [3H]spiperone. In vivo demonstration involved autoradiographic analysis of [3H]spiperone binding in rat striatum following injection of the adenoviral vector. Dopamine D2 receptor expression was amplified markedly above normal concentrations in the injection site, whereas no increased expression was observed in sites receiving control treatments. These results demonstrate the potential of gene therapy using adenoviral vectors to transfer neurotransmitter receptor proteins to the brain to reverse deficiencies in specific neurodegenerative disorders.

Original languageEnglish
Pages (from-to)315-320
Number of pages6
JournalMolecular Brain Research
Volume34
Issue number2
DOIs
Publication statusPublished - 28 Dec 1995
Externally publishedYes

Fingerprint

Dopamine D2 Receptors
Adenoviridae
Complementary DNA
Spiperone
Neurotransmitter Receptor
Genes
Neurodegenerative Diseases
Neostriatum
Injections
Huntington Disease
Brain
Genetic Therapy
Parkinson Disease
Membrane Proteins
Cell Culture Techniques
Ligands
Messenger RNA
Therapeutics
Proteins

Keywords

  • Aging
  • Gene therapy
  • Huntington's disease
  • Motor performance
  • Neurotransmitter receptor
  • Parkinson's disease

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Ikari, H., Liang, Z., Chernak, J. M., Mastrangeli, A., Kato, S., Kuo, H., ... Roth, G. S. (1995). Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. Molecular Brain Research, 34(2), 315-320. https://doi.org/10.1016/0169-328X(95)00185-U

Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. / Ikari, Hiroyuki; Liang, Zhang; Chernak, Jeffrey M.; Mastrangeli, Andrea; Kato, Shuichi; Kuo, Hui; Crystal, Ronald; Ingram, Donald K.; Roth, George S.

In: Molecular Brain Research, Vol. 34, No. 2, 28.12.1995, p. 315-320.

Research output: Contribution to journalArticle

Ikari, H, Liang, Z, Chernak, JM, Mastrangeli, A, Kato, S, Kuo, H, Crystal, R, Ingram, DK & Roth, GS 1995, 'Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum', Molecular Brain Research, vol. 34, no. 2, pp. 315-320. https://doi.org/10.1016/0169-328X(95)00185-U
Ikari, Hiroyuki ; Liang, Zhang ; Chernak, Jeffrey M. ; Mastrangeli, Andrea ; Kato, Shuichi ; Kuo, Hui ; Crystal, Ronald ; Ingram, Donald K. ; Roth, George S. / Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum. In: Molecular Brain Research. 1995 ; Vol. 34, No. 2. pp. 315-320.
@article{ad38b31d07b540ecadc1a5f73f3b0d02,
title = "Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum",
abstract = "A robust feature of mammalian aging associated with diminished motor control is the loss of dopamine D2 receptors from the neostriatum. Decline in this neurotransmitter receptor is also observed in neurodegenerative disorders, such as Huntington's disease and late-stage Parkinson's disease. We have constructed a replication-deficient adenoviral vector to transfer rat dopamine D2 receptor cDNA to brain as a possible therapeutic strategy. Using tissue culture cells infected with this vector, we detected dopamine D2 receptor mRNA by Northern analysis and functional receptor protein in membrane preparations as specific binding of the dopamine D2 receptor ligand, [3H]spiperone. In vivo demonstration involved autoradiographic analysis of [3H]spiperone binding in rat striatum following injection of the adenoviral vector. Dopamine D2 receptor expression was amplified markedly above normal concentrations in the injection site, whereas no increased expression was observed in sites receiving control treatments. These results demonstrate the potential of gene therapy using adenoviral vectors to transfer neurotransmitter receptor proteins to the brain to reverse deficiencies in specific neurodegenerative disorders.",
keywords = "Aging, Gene therapy, Huntington's disease, Motor performance, Neurotransmitter receptor, Parkinson's disease",
author = "Hiroyuki Ikari and Zhang Liang and Chernak, {Jeffrey M.} and Andrea Mastrangeli and Shuichi Kato and Hui Kuo and Ronald Crystal and Ingram, {Donald K.} and Roth, {George S.}",
year = "1995",
month = "12",
day = "28",
doi = "10.1016/0169-328X(95)00185-U",
language = "English",
volume = "34",
pages = "315--320",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum

AU - Ikari, Hiroyuki

AU - Liang, Zhang

AU - Chernak, Jeffrey M.

AU - Mastrangeli, Andrea

AU - Kato, Shuichi

AU - Kuo, Hui

AU - Crystal, Ronald

AU - Ingram, Donald K.

AU - Roth, George S.

PY - 1995/12/28

Y1 - 1995/12/28

N2 - A robust feature of mammalian aging associated with diminished motor control is the loss of dopamine D2 receptors from the neostriatum. Decline in this neurotransmitter receptor is also observed in neurodegenerative disorders, such as Huntington's disease and late-stage Parkinson's disease. We have constructed a replication-deficient adenoviral vector to transfer rat dopamine D2 receptor cDNA to brain as a possible therapeutic strategy. Using tissue culture cells infected with this vector, we detected dopamine D2 receptor mRNA by Northern analysis and functional receptor protein in membrane preparations as specific binding of the dopamine D2 receptor ligand, [3H]spiperone. In vivo demonstration involved autoradiographic analysis of [3H]spiperone binding in rat striatum following injection of the adenoviral vector. Dopamine D2 receptor expression was amplified markedly above normal concentrations in the injection site, whereas no increased expression was observed in sites receiving control treatments. These results demonstrate the potential of gene therapy using adenoviral vectors to transfer neurotransmitter receptor proteins to the brain to reverse deficiencies in specific neurodegenerative disorders.

AB - A robust feature of mammalian aging associated with diminished motor control is the loss of dopamine D2 receptors from the neostriatum. Decline in this neurotransmitter receptor is also observed in neurodegenerative disorders, such as Huntington's disease and late-stage Parkinson's disease. We have constructed a replication-deficient adenoviral vector to transfer rat dopamine D2 receptor cDNA to brain as a possible therapeutic strategy. Using tissue culture cells infected with this vector, we detected dopamine D2 receptor mRNA by Northern analysis and functional receptor protein in membrane preparations as specific binding of the dopamine D2 receptor ligand, [3H]spiperone. In vivo demonstration involved autoradiographic analysis of [3H]spiperone binding in rat striatum following injection of the adenoviral vector. Dopamine D2 receptor expression was amplified markedly above normal concentrations in the injection site, whereas no increased expression was observed in sites receiving control treatments. These results demonstrate the potential of gene therapy using adenoviral vectors to transfer neurotransmitter receptor proteins to the brain to reverse deficiencies in specific neurodegenerative disorders.

KW - Aging

KW - Gene therapy

KW - Huntington's disease

KW - Motor performance

KW - Neurotransmitter receptor

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0029560924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029560924&partnerID=8YFLogxK

U2 - 10.1016/0169-328X(95)00185-U

DO - 10.1016/0169-328X(95)00185-U

M3 - Article

VL - 34

SP - 315

EP - 320

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -